- Home
- FNLC vs NAUT Comparison
FNLC vs NAUT Comparison
Compare FNLC & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNLC
- NAUT
- Stock Information
- Founded
- FNLC 1864
- NAUT 2016
- Country
- FNLC United States
- NAUT United States
- Employees
- FNLC N/A
- NAUT N/A
- Industry
- FNLC Major Banks
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- FNLC Finance
- NAUT Industrials
- Exchange
- FNLC Nasdaq
- NAUT Nasdaq
- Market Cap
- FNLC 303.4M
- NAUT 104.7M
- IPO Year
- FNLC 1999
- NAUT N/A
- Fundamental
- Price
- FNLC $25.11
- NAUT $1.52
- Analyst Decision
- FNLC
- NAUT Strong Sell
- Analyst Count
- FNLC 0
- NAUT 1
- Target Price
- FNLC N/A
- NAUT $1.75
- AVG Volume (30 Days)
- FNLC 21.4K
- NAUT 830.8K
- Earning Date
- FNLC 10-22-2025
- NAUT 10-28-2025
- Dividend Yield
- FNLC 5.88%
- NAUT N/A
- EPS Growth
- FNLC 18.07
- NAUT N/A
- EPS
- FNLC 2.81
- NAUT N/A
- Revenue
- FNLC $88,119,000.00
- NAUT N/A
- Revenue This Year
- FNLC N/A
- NAUT N/A
- Revenue Next Year
- FNLC N/A
- NAUT N/A
- P/E Ratio
- FNLC $9.06
- NAUT N/A
- Revenue Growth
- FNLC 12.70
- NAUT N/A
- 52 Week Low
- FNLC $22.11
- NAUT $0.62
- 52 Week High
- FNLC $31.05
- NAUT $2.92
- Technical
- Relative Strength Index (RSI)
- FNLC 46.36
- NAUT 58.99
- Support Level
- FNLC $24.39
- NAUT $1.44
- Resistance Level
- FNLC $25.46
- NAUT $1.87
- Average True Range (ATR)
- FNLC 0.46
- NAUT 0.25
- MACD
- FNLC 0.06
- NAUT 0.01
- Stochastic Oscillator
- FNLC 39.04
- NAUT 57.31
About FNLC First Bancorp Inc (ME)
First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services including deposit accounts and consumer, commercial and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.